Author:
Chan S.,Griffin M.,Stewart J.,Gregory K.,Hughes A.,Awwad S.,Allerton R.,Pledge S.,Thomas H.,Percival F.
Subject
Radiology Nuclear Medicine and imaging,Oncology
Reference12 articles.
1. National Institute of Clinical Excellence. Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer, a review of Technology Appraisal Guidance 28, 45 and 55. Technology Appraisal 91: 25 May 2005.
2. Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit;Kirwan;Br Med J,2002
3. National Institute of Clinical Excellence. Ovarian cancer – taxanes. Technology Appraisal 3: May 2000.
4. National Institute of Clinical Excellence. Guidance on the use of topotecan for the treatment of advanced ovarian cancer. Technology Appraisal 28: August 2001.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献